All

Investigational Injectable Drug Demonstrates Efficacy in Localized Fat Reduction

Participants experienced an average reduction of 28.1% of subcutaneous fat volume compared with placebo.

All

Sorry, No Posts Found

All

Galderma’s Relfydess Approved in China for Treatment of Frown Lines

The ready-to-use liquid botulinum toxin treatment requires no reconstitution. Phase III trials showed improvements in frown lines, with some patients maintaining results for up to six months.

Allergan Aesthetics Updates APP to Reflect Changing Practice Needs
CareCredit Launches CareCredit Pay Later Installment Loan Option
Restylane Skinboosters and Sculptra May Improve Menopausal Skin. A New Study Examines Which Treatment Order Works Better

Tag: CBL-514

All

Investigational Injectable Drug Demonstrates Efficacy in Localized Fat Reduction

All

Sorry, No Posts Found

All

Galderma’s Relfydess Approved in China for Treatment of Frown Lines

Allergan Aesthetics Updates APP to Reflect Changing Practice Needs

CareCredit Launches CareCredit Pay Later Installment Loan Option

Restylane Skinboosters and Sculptra May Improve Menopausal Skin. A New Study Examines Which Treatment Order Works Better

Sorry, No Posts Found

Plastic Surgery Practice

Our Parent Company

Key Resources

Helpful Links